Lomefloxacin
- Level
- Commodity
- Parent
- 51282900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282927This classification denotes a quinolone antibiotic with the molecular formula C17H19F2N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6BR2WJD8V, chemically known as 1,4-dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid but generally known as lomefloxacin, which bears US NIH Compound Identifier 3948. European Medicines Agency schedules Lomefloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08561MIG. The term LOMEFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). World Health Organization schedules lomefloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. LOMEFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lomefloxacin under HS 29335995 and SITC 51576. As of Q4 2014, LOMEFLOXACIN remains the US FDA Preferred Term for this commodity. Lomefloxacin bears US NLM identifiers UMLS ID C0065162 and NCI Concept Code C61814. SMILES: FC1C(N2CC(NCC2)C)C(F)CC2C1N(CC)CC(C2=O)C(=O)O.
Same parent
Under 51282900 · 57Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.